The APAC Glaucoma Surgery Devices Market Analysis Executive Summary
Glaucoma surgery devices lower eye pressure using tiny stents, shunts and lasers, often during cataract surgery.
Key segments of the glaucoma Surgery Devices market include product (MIGS Devices, Glaucoma Drainage Devices and Laser Systems) and procedure (Standalone and Combined with Cataract Surgery).
APAC Glaucoma Surgery Devices Market Dynamics
Market Growth Drivers
An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the glaucoma Surgery Devices market.
Opportunity
Longer-acting treatments, home-based care and screening in emerging markets give the glaucoma Surgery Devices market room to grow.
Market Restraints
High costs of new treatments, specialist shortages, low awareness and limited reimbursement in some countries hold back the glaucoma Surgery Devices market.
Competitive Landscape for Glaucoma Surgery Devices Market in APAC
The glaucoma Surgery Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Key Players
Healthcare Policies and Regulatory Landscape for Glaucoma Surgery Devices Market in APAC
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how glaucoma Surgery Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.
The glaucoma Surgery Devices market can be segmented based on various criteria, including product, procedure and end user. Here's a breakdown of the market segmentation
By Product
- MIGS Devices
- Glaucoma Drainage Devices
- Laser Systems
By Procedure
- Standalone
- Combined with Cataract Surgery
By End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Home Care Settings
Also active in this area
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.